Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Molecular Characterization of Advanced-Stage Melanomas in Clinical Practice Using a Laboratory-Developed Next-Generation Sequencing Panel.
Maloberti T, De Leo A, Coluccelli S, Sanza V, Gruppioni E, Altimari A, Comito F, Melotti B, Marchese PV, Dika E, Venturi F, Corti B, Ciccimarra G, Ciceu CA, Tallini G, de Biase D. Maloberti T, et al. Diagnostics (Basel). 2024 Apr 11;14(8):800. doi: 10.3390/diagnostics14080800. Diagnostics (Basel). 2024. PMID: 38667446 Free PMC article.
Accuracy of World Health Organisation-grade parameters (necrosis and mitotic activity) and foci of vascular invasion in predicting prognosis of papillary thyroid carcinoma. A case-control validation study.
Ragazzi M, Besutti G, Mancuso P, Rossi PG, Ciarrocchi A, Donati B, Manzotti G, Giordano D, Frasoldati A, Chiaruccci F, de de Biase D, Coluccelli S, Maloberti T, De Leo A, Piana S, Tallini G. Ragazzi M, et al. Among authors: maloberti t. Histopathology. 2024 Mar 13. doi: 10.1111/his.15173. Online ahead of print. Histopathology. 2024. PMID: 38477417
TERT promoter mutations and the outcome of patients with advanced urothelial carcinoma treated by platinum-based chemotherapy or pembrolizumab.
Mollica V, Tassinari E, Santoni M, Marchese PV, Giunchi F, Maloberti T, Tateo V, Ricci C, Rosellini M, Marchetti A, Fiorentino M, Biase D, Massari F. Mollica V, et al. Among authors: maloberti t. Pathol Res Pract. 2024 Jan;253:155008. doi: 10.1016/j.prp.2023.155008. Epub 2023 Dec 8. Pathol Res Pract. 2024. PMID: 38103361
Clinical relevance of gene mutations and rearrangements in advanced differentiated thyroid cancer.
Nannini M, Repaci A, Nigro MC, Colapinto A, Vicennati V, Maloberti T, Gruppioni E, Altimari A, Solaroli E, Lodi Rizzini E, Monari F, De Leo A, Damiani S, Pagotto U, Pantaleo MA, de Biase D, Tallini G. Nannini M, et al. Among authors: maloberti t. ESMO Open. 2023 Dec;8(6):102039. doi: 10.1016/j.esmoop.2023.102039. Epub 2023 Oct 23. ESMO Open. 2023. PMID: 37879236 Free PMC article.
Evaluation of an institutional series of low-grade oncocytic tumor (LOT) of the kidney and review of the mutational landscape of LOT.
Ricci C, Ambrosi F, Franceschini T, Giunchi F, Grillini A, Franchini E, Grillini M, Schiavina R, Massari F, Mollica V, Tateo V, Bianchi FM, Bianchi L, Droghetti M, Maloberti T, Tallini G, Colecchia M, Acosta AM, Lobo J, Trpkov K, Fiorentino M, de Biase D. Ricci C, et al. Among authors: maloberti t. Virchows Arch. 2023 Nov;483(5):687-698. doi: 10.1007/s00428-023-03673-9. Epub 2023 Oct 17. Virchows Arch. 2023. PMID: 37845471 Free PMC article. Review.
30 results